176 related articles for article (PubMed ID: 15625562)
1. Inhibition of CYP17 expression by adrenal androgens and transforming growth factor beta in adrenocortical cells.
Biernacka-Łukanty JM; Lehmann TP; Trzeciak WH
Acta Biochim Pol; 2004; 51(4):907-17. PubMed ID: 15625562
[TBL] [Abstract][Full Text] [Related]
2. SMAD3 inhibits SF-1-dependent activation of the CYP17 promoter in H295R cells.
Derebecka-Holysz N; Lehmann TP; Holysz M; Trzeciak WH
Mol Cell Biochem; 2008 Jan; 307(1-2):65-71. PubMed ID: 17786540
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone inhibits corticotropin-induced accumulation of CYP11A and CYP17 messenger RNAs in bovine adrenocortical cells.
Trzeciak WH; LeHoux JG; Waterman MR; Simpson ER
Mol Endocrinol; 1993 Feb; 7(2):206-13. PubMed ID: 8385739
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta inhibits CYP17 transcription in H295R cells acting via activin receptor-like kinase 5.
Derebecka-Holysz N; Lehmann TP; Holysz M; Trzeciak WH
Endocr Res; 2009; 34(3):68-79. PubMed ID: 19701832
[TBL] [Abstract][Full Text] [Related]
5. Differential control of 17 alpha-hydroxylase and 3 beta-hydroxysteroid dehydrogenase expression in human adrenocortical H295R cells.
Bird IM; Pasquarette MM; Rainey WE; Mason JI
J Clin Endocrinol Metab; 1996 Jun; 81(6):2171-8. PubMed ID: 8964847
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the potential of polyphenols as a CYP17 inhibitor free of adverse corticosteroid elevation.
Lin CJ; Cheng LC; Lin TC; Wang CJ; Li LA
Biochem Pharmacol; 2014 Aug; 90(3):288-96. PubMed ID: 24875446
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factors augment steroid production and expression of steroidogenic enzymes in human fetal adrenal cortical cells: implications for adrenal androgen regulation.
Mesiano S; Katz SL; Lee JY; Jaffe RB
J Clin Endocrinol Metab; 1997 May; 82(5):1390-6. PubMed ID: 9141522
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta inhibits steroid 17 alpha-hydroxylase cytochrome P-450 expression in ovine adrenocortical cells.
Rainey WE; Naville D; Saez JM; Carr BR; Byrd W; Magness RR; Mason JI
Endocrinology; 1990 Oct; 127(4):1910-5. PubMed ID: 2169408
[TBL] [Abstract][Full Text] [Related]
9. Regulation of 3 beta-hydroxysteroid dehydrogenase expression in human adrenocortical H295R cells.
Bird IM; Imaishi K; Pasquarette MM; Rainey WE; Mason JI
J Endocrinol; 1996 Sep; 150 Suppl():S165-73. PubMed ID: 8943800
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone inhibits androgen production in NCI-H295R cells by regulating gene expression of CYP17 and HSD3B2.
Kempná P; Hofer G; Mullis PE; Flück CE
Mol Pharmacol; 2007 Mar; 71(3):787-98. PubMed ID: 17138841
[TBL] [Abstract][Full Text] [Related]
11. TPA inhibits the synthesis of androgens and cortisol and enhances the synthesis non-17 alpha-hydroxylated steroids in cultured human adrenocortical cells.
McAllister JM; Hornsby PJ
Endocrinology; 1987 Nov; 121(5):1908-10. PubMed ID: 3499311
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta 1 is a negative regulator of steroid 17 alpha-hydroxylase expression in bovine adrenocortical cells.
Perrin A; Pascal O; Defaye G; Feige JJ; Chambaz EM
Endocrinology; 1991 Jan; 128(1):357-62. PubMed ID: 1986928
[TBL] [Abstract][Full Text] [Related]
13. Effects of transforming growth factor beta on ovine adrenocortical cells.
Rainey WE; Viard I; Mason JI; Cochet C; Chambaz EM; Saez JM
Mol Cell Endocrinol; 1988 Dec; 60(2-3):189-98. PubMed ID: 2850957
[TBL] [Abstract][Full Text] [Related]
14. Ovine fetal adrenal synthesis of cortisol: regulation by adrenocorticotropin, angiotensin II and transforming growth factor-beta.
Rainey WE; Oka K; Magness RR; Mason JI
Endocrinology; 1991 Oct; 129(4):1784-90. PubMed ID: 1655383
[TBL] [Abstract][Full Text] [Related]
15. ACTH angiotensin II and TGF beta participate in the regulation of steroidogenesis in bovine adrenal glomerulosa cells.
Galtier A; Liakos P; Keramidas M; Feige JJ; Chambaz EM; Defaye G
Endocr Res; 1996 Nov; 22(4):607-12. PubMed ID: 8969919
[TBL] [Abstract][Full Text] [Related]
16. Regulation of 3 beta-hydroxysteroid dehydrogenase in adrenocortical cells: effects of angiotensin-II and transforming growth factor beta.
Rainey WE; Naville D; Mason JI
Endocr Res; 1991; 17(1-2):281-96. PubMed ID: 1652433
[TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP-stimulated interaction between steroidogenic factor 1 and diacylglycerol kinase theta facilitates induction of CYP17.
Li D; Urs AN; Allegood J; Leon A; Merrill AH; Sewer MB
Mol Cell Biol; 2007 Oct; 27(19):6669-85. PubMed ID: 17664281
[TBL] [Abstract][Full Text] [Related]
18. Human adrenal corticocarcinoma NCI-H295R cells produce more androgens than NCI-H295A cells and differ in 3beta-hydroxysteroid dehydrogenase type 2 and 17,20 lyase activities.
Samandari E; Kempná P; Nuoffer JM; Hofer G; Mullis PE; Flück CE
J Endocrinol; 2007 Dec; 195(3):459-72. PubMed ID: 18000308
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase A, protein kinase C, and Ca(2+)-regulated expression of 21-hydroxylase cytochrome P450 in H295R human adrenocortical cells.
Bird IM; Mason JI; Rainey WE
J Clin Endocrinol Metab; 1998 May; 83(5):1592-7. PubMed ID: 9589661
[TBL] [Abstract][Full Text] [Related]
20. Impact of differential P450c17 phosphorylation by cAMP stimulation and by starvation conditions on enzyme activities and androgen production in NCI-H295R cells.
Kempná P; Hirsch A; Hofer G; Mullis PE; Flück CE
Endocrinology; 2010 Aug; 151(8):3686-96. PubMed ID: 20534731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
